Latest News

AAN report: long-term data for anti-CD20s, BTK inhibitors

April 25, 2022  

A number of new studies have provided data on the long-term safety and efficacy of high-efficacy disease-modifying therapies in MS. The data were presented at the American Academy of Neurology (AAN) annual meeting, held April 2-7 in Seattle, Washington. The following is a summary of key studies. Read More

CLINICAL CASES IN MS – CASE 4: WORSENING SYMPTOMS IN A WOMAN WITH STABLE EDSS

April 21, 2022  

Click here to watch Dr. Daniel Selchen discuss the case and the responses to the survey.

Kay, 39 years old, is sales clerk at a downtown department store. In 2009, at age 27 years, she was diagnosed with RRMS. Her initial presentation was optic neuritis, but she subsequently developed brainstem symptoms, including  mild vertigo and difficulty swallowing. There was no family history of demyelinating or autoimmune disorders. There was no significant medical history and no comorbidities. Read More

Neurological sequelae of COVID-19 infection

April 19, 2022  

A number of recent studies have reported on the incidence of acute neurological complications of COVID-19 infection, as well as long-term complications, variously called PASC (post-acute sequelae of COVID-19) or ‘long COVID’. Data were reported at the American Academy of Neurology annual meeting, held April 2-7 in Seattle, Washington. Read More